ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

GERALD MCAULIFFE M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,725Medicare Part D Prescriptions Filled, Including Refills

Rank: 254 out of 1006

$412K Total Retail Price of All Prescriptions

Rank: 313 out of 1006

392 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 6,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 415 391 1 3
LEVOTHYROXINE SODIUM 342 308 2 2
SIMVASTATIN 300 285 3 1
AMLODIPINE BESYLATE 259 246 4 4
METOPROLOL TARTRATE 219 214 5 7
ATORVASTATIN CALCIUM 204 199 6 5
METFORMIN HCL 144 137 7 10
ATENOLOL 140 140 8 13
HYDROCHLOROTHIAZIDE 135 129 9 11
WARFARIN SODIUM 131 131 10 8
METOPROLOL SUCCINATE 123 123 11 12
FUROSEMIDE 121 121 12 6
PRAVASTATIN SODIUM 110 104 13 15
MIRTAZAPINE 102 102 14 26
SERTRALINE HCL 99 81 15 19
OMEPRAZOLE 87 74 16 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 71 17 38
RISPERIDONE 71 66 17 40
TRAZODONE HCL 68 68 19 21
METFORMIN HCL ER 66 66 20 56
LOSARTAN POTASSIUM 64 64 21 22
OLANZAPINE 64 64 21 68
CITALOPRAM HBR 63 60 23 24
DONEPEZIL HCL 63 63 23 17
SYNTHROID 61 59 25 42
NEXIUM 60 39 26 28
RANITIDINE HCL 60 60 26 63
GLIMEPIRIDE 57 57 28 50
CARVEDILOL 56 50 29 36
ALLOPURINOL 52 52 30 31
ZOLPIDEM TARTRATE 51 51 31 14
HYDROCODONE-ACETAMINOPHEN 51 42 S3 31 25
QUETIAPINE FUMARATE 50 50 33 45
ESCITALOPRAM OXALATE 50 49 33 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.